The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Noninvasive monitoring of dynamics of acquired EGFR-T790M mutation and discovery of its heterogeneity in patients with advanced NSCLC treated with EGFR-TKI.
Di Zheng
Honoraria - AstraZeneca; Lilly; Roche
Research Funding - AstraZeneca
Xin Ye
No relevant relationships to disclose
Yun Sun
No relevant relationships to disclose
Meizhuo Zhang
No relevant relationships to disclose
Jiying Wang
No relevant relationships to disclose
Jie Zhang
No relevant relationships to disclose
Jian Ni
Honoraria - AstraZeneca; Lilly; Roche
Ling Zhang
No relevant relationships to disclose
Haiping Zhang
No relevant relationships to disclose
Jie Luo
No relevant relationships to disclose
Liang Tang
No relevant relationships to disclose
Bo Su
No relevant relationships to disclose
Gang Chen
Honoraria - Lilly
Guanshan Zhu
No relevant relationships to disclose
Yi Gu
Stock Ownership - AstraZeneca
Jianfang Xu
Honoraria - AstraZeneca; Lilly; Mundipharma; Roche
Research Funding - AstraZeneca